Computed tomography-guided additive manufacturing of Personalized Absorbable Gastrointestinal Stents for intestinal fistulae and perforations.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
01 2020
Historique:
received: 16 06 2019
revised: 05 10 2019
accepted: 10 10 2019
pubmed: 5 11 2019
medline: 15 5 2021
entrez: 4 11 2019
Statut: ppublish

Résumé

Small bowel perforations and obstructions are relatively frequent surgical emergencies, are potentially life-threatening, and have multiple etiologies. In general, treatment requires urgent surgical repair or resection and at times can lead to further complications. Stents may be used to help with healing intestinal perforations but use is limited as currently available stents are non-absorbable, are manufactured in a narrow size range, and/or are limited to usage in locations that are accessible for endoscopic removal post-healing. The use of 3D-printed bioresorbable polymeric stents will provide patients with a stent that can prevent leakage, is tailored specifically to their geometry, and will be usable within the small bowel, which is not amenable to endoscopic stent placement. This work focused on the rapid manufacturing of gastrointestinal stents composed of a polycaprolactone-polydioxanone (PCL-PDO) composite. Dynamic Mechanical Analysis (DMA) tests were conducted to separately analyze the effects of composition, the filament formation process, and physiological temperature on the PCL-PDO material properties. The proposed stent design was then modeled using computer-aided design, and Finite Element Analysis (FEA) was used to simulate the effects of physiologically relevant forces on stent integrity. The presence of hydrolysable ester bonds was confirmed using FT-IR spectroscopy. In vitro studies were used to evaluate the biocompatibility of the polymer composite. Further analyses were conducted through stent placement in ex vivo pig intestines. PCL-PDO stents were then 3D-printed and placed in vivo in a pig model.

Identifiants

pubmed: 31678842
pii: S0142-9612(19)30641-6
doi: 10.1016/j.biomaterials.2019.119542
pmc: PMC7982053
mid: NIHMS1609101
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

119542

Subventions

Organisme : NIBIB NIH HHS
ID : T32 EB019944
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Biomaterials. 2009 Sep;30(26):4407-15
pubmed: 19487022
Vet Surg. 2017 May;46(4):486-493
pubmed: 28314067
Ann Surg. 2007 Feb;245(2):254-8
pubmed: 17245179
Biomed Mater. 2017 Nov 22;13(1):015006
pubmed: 29165317
Circulation. 2008 Dec 9;118(24):2563-70
pubmed: 19029464
J Biomater Sci Polym Ed. 2011;22(1-3):225-37
pubmed: 20557697
Acta Biomater. 2011 Jan;7(1):295-303
pubmed: 20656079
Gastroenterology. 1959 May;36(5):661-71
pubmed: 13653288
Eur Cell Mater. 2017 Feb 20;33:169-182
pubmed: 28266691
Eur J Pharm Biopharm. 2015 Nov;97(Pt B):371-91
pubmed: 26614558
Am Surg. 2009 Jan;75(1):30-2
pubmed: 19213393
J Colloid Interface Sci. 2004 May 15;273(2):381-7
pubmed: 15082371
Eur Radiol. 2011 Sep;21(9):1956-61
pubmed: 21533633
Sci Transl Med. 2015 Apr 29;7(285):285ra64
pubmed: 25925683
Colloids Surf B Biointerfaces. 2010 Jan 1;75(1):1-18
pubmed: 19782542
Sci Rep. 2017 Jun 15;7(1):3615
pubmed: 28620160
Arthroscopy. 2006 Nov;22(11):1146-53
pubmed: 17084288
Int J Pharm. 2014 Jan 1;459(1-2):62-4
pubmed: 24239831
Clin Colon Rectal Surg. 2010 Sep;23(3):190-4
pubmed: 21886469
J Biomed Mater Res A. 2007 Mar 1;80(3):655-60
pubmed: 17051539
J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):1662-1671
pubmed: 28842967
J Thorac Cardiovasc Surg. 2012 Feb;143(2):437-44
pubmed: 21885070
P T. 2014 Oct;39(10):704-11
pubmed: 25336867
Bioconjug Chem. 1998 Sep-Oct;9(5):564-72
pubmed: 9736490
Biomaterials. 2006 Jul;27(19):3608-16
pubmed: 16530824
Biomed Mater. 2009 Oct;4(5):055010
pubmed: 19815970

Auteurs

Parinaz Fathi (P)

Departments of Bioengineering, Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, United States.

Gweneviere Capron (G)

Carle Foundation Hospital, Urbana, IL, United States.

Indu Tripathi (I)

Departments of Bioengineering, Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, United States.

Santosh Misra (S)

Departments of Bioengineering, Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, United States.

Fatemeh Ostadhossein (F)

Departments of Bioengineering, Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, United States.

Laura Selmic (L)

College of Veterinary Medicine, University of Illinois, Urbana, Champaign, IL, United States.

Blair Rowitz (B)

Carle Foundation Hospital, Urbana, IL, United States; Carle Illinois College of Medicine, University of Illinois, Urbana, Champaign, IL, United States.

Dipanjan Pan (D)

Departments of Bioengineering, Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, United States; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, 61801, United States; Carle Illinois College of Medicine, University of Illinois, Urbana, Champaign, IL, United States. Electronic address: dipanjan@illinois.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH